IP Library › Assignment 026825/0898
Patent Assignment
Reel/Frame 026825/0898

Assignment of Assignor's Interest

Recorded: 2011-08-30 Pages: 2
Assignor
HANSEN, HENRIK C.
Executed: 2011-08-10
Assignee
RESVERLOGIX CORPORATION
279 MIDPARK WAY SE, SUITE 202, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Compounds for the Prevention and Treatment of Cardiovascular Disease
Patent: 8,952,021 →
Application: 13/143,757 →
Publication: US 2011/0294807
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 026825 Frame 0898. Assignor(S) Hereby Confirms the Assignee Name Is Resverlogix Corp.. Sep 30, 2011
From: HANSEN, HENRIK C.
To: RESVERLOGIX CORP.
Reel/Frame 026999/0545 →
Security Interest Jun 14, 2018
From: RESVERLOGIX CORP.
To: THIRD EYE CAPITAL CORPORATION
Reel/Frame 046090/0103 →
Security Interest Sep 27, 2019
From: RESVERLOGIX CORP.
To: VISION LEADER LIMITED
Reel/Frame 050518/0714 →
Release of Security Interest Oct 17, 2019
From: THIRD EYE CAPITAL CORPORATION
To: RESVERLOGIX CORP.
Reel/Frame 050763/0175 →
Release of Security Interest Jan 12, 2021
From: VISION LEADER LIMITED
To: RESVERLOGIX CORP.
Reel/Frame 054888/0506 →